Esketamine Alternatives Compared
| Esketamine | Rexulti (brexpiprazole) | Bupropion |
|
|---|
| Esketamine | Rexulti (brexpiprazole) | Bupropion |
|
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Depression, Major Depressive Disorder, Major Depressive Disorder with Acute Suicidal Ideation. Esketamine may also be used for purposes not listed in this medication guide. |
Prescription only
Rexulti is an atypical antipsychotic that may be used to treat adults with schizophrenia or depression, or used to relieve agitation associated with dementia in Alzheimer's disease. Most people... View more |
Prescription only
Bupropion is used to treat major depressive disorder and seasonal affective disorder and is chemically distinct from other antidepressants. It is also used for smoking cessation, and is significantly... View more |
Related suggestionsDepressionMajor Depressive Disorder |
|||||||||||||||||||
| More about Esketamine | More about Rexulti (brexpiprazole) | More about Bupropion | ||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||
|
Esketamine has an average rating of 6.2 out of 10 from a total of 147 ratings on Drugs.com. 48% of reviewers reported a positive effect, while 29% reported a negative effect. |
Rexulti has an average rating of 6.6 out of 10 from a total of 566 ratings on Drugs.com. 54% of reviewers reported a positive effect, while 25% reported a negative effect. |
Bupropion has an average rating of 7.0 out of 10 from a total of 2972 ratings on Drugs.com. 61% of reviewers reported a positive effect, while 20% reported a negative effect. |
||||||||||||||||||||
|
View all 147 reviews |
View all 566 reviews |
View all 2972 reviews |
||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||
View all side effects |
View all side effects |
View all side effects |
||||||||||||||||||||
| Boxed Warnings A boxed warning is the most serious warning from the Food and Drug Administration (FDA) about drug effects that may be dangerous. | ||||||||||||||||||||||
|
View boxed warnings |
View boxed warnings |
View boxed warnings |
||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||
| Generic Availability Learn more about brand vs generic drugs. | ||||||||||||||||||||||
|
N/A |
Lower cost generic |
|||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance. | ||||||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
|
||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||
|
N/A |
|
|
||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||
| Spravato |
N/A |
Aplenzin, Budeprion, Budeprion SR, Forfivo XL, Wellbutrin SR, Wellbutrin XL | ||||||||||||||||||||
| Half Life Learn about the half-life of a drug and how it is calculated. | ||||||||||||||||||||||
|
12 hours |
91 hours |
30 hours |
||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||
|
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category C
See the full pregnancy warnings document. |
||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||
|
A total of 302 drugs are known to interact with Esketamine:
|
A total of 619 drugs are known to interact with Rexulti:
|
A total of 578 drugs are known to interact with Bupropion:
|
||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||
|
|
|
||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||
|
N/A |
July 10, 2015 |
December 30, 1985 |
||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||
| More Information | ||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||
|
||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.